TD Asset Management »

Immunome shares owned by TD Asset Management

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by TD Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.4M 127k 10.70
2023-09-30 $1.1M 127k 8.35

More positions owned by TD Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Bank Of Montreal Cadcom (BMO)
NVIDIA Corporation (NVDA)
Canadian Pacific Kansas City (CP)
UnitedHealth (UNH)
Canadian Natl Ry (CNI)
Amazon (AMZN)
Visa Com Cl A (V)
Canadian Natural Resources (CNQ)
Enbridge (ENB)
Eli Lilly & Co. (LLY)

View all positions for TD Asset Management

Top funds holding Immunome

EcoR1 Capital
Redmile Group
Vanguard Group
Henderson Group
Avidity Partners Management
T. Rowe Price Associates
Point72 Asset Management
Brown Advisory Holdings Incorporated
Alpine Partners VI
TD Asset Management
Prentice Capital Management
Jane Street
Laurion Capital Management
Barclays
HPM Partners

View all funds holding Immunome